CytomX Stock Jumps 55% Following Partnership with Moderna
CytomX Therapeutics shares (NASDAQ: CTMX) saw a 55.3% increase in after-market trading on January 5th following the announcement of their collaboration with Moderna to…
PHARMA
PHARMA
Read More
Spruce Biosciences and Kaken Pharma Partner to Develop Tildacerfont
Spruce Biosciences stock (NASDAQ: SPRB) are seeing a significant increase on Friday following the news of their partnership with Kaken Pharmaceutical to develop tildacerfont,…
Why Novocure Stock Price 49.8% Soars Today
What happened With Novocure Stock Novocure stock price (NASDAQ: NVCR) has experienced a 49.8% increase as of 10:12 a.m. on Thursday. This significant growth…
Aurinia and Sun Pharmaceuticals settle patent challenge for LUPKYNIS®.
Aurinia (NASDAQ: AUPH) has announced that it has reached a settlement with Sun Pharmaceuticals in regards to a patent challenge for LUPKYNIS® (voclosporin). Due to…
Stock in News: TSLA, KALA, BLI, UCL, UTRS, ARB, JNCE
In this post, we are going to talk about all the news of 28 December 2022 which you should keep in mind. Stock In…
Stock in News: TSLA, AMC, UBER, MU, KMX, BCRX, KR, AVO, WVE, DFLI, NTNX
In this post, we are going to talk about all the news of 23 December 2022 which you should keep in mind. Stock In…
Why Prometheus Biosciences Shares Soared 176%
Prometheus Biosciences (NASDAQ: RXDX) share today 7th December 2022 gained 176% and Prometheus Biosciences share opened at 105.07 USD from 36.06 USD. Now let…
Today’s Commodity Stocks “Strong Purchase” 2 Stocks That Could Take to $15
These stock are highly appealing for risk takers. Looking at this price, you can get more for your money. On these titles, even a…
Why Apollo Endosurgery stock gained 66%
Boston Scientific Corporation has announced that this company has entered into an agreement to buy shares of Apollo endosurgery inc. at a price of…
Why Imago Biosciences Stocks Soared 104%
Shares of Imago BioSciences Inc. closed at a price of $17.40 on Friday, after which a news came on Monday, due to which the…